Back to top

Image: Shutterstock

Zacks Investment Ideas feature highlights: Pfizer, BioNTech, Delta Air Lines, Disney and Peloton Interactive

Read MoreHide Full Article

For Immediate Release

Chicago, IL – November 10, 2020 – Today, Zacks Investment Ideas feature highlights Features: Pfizer Inc. (PFE - Free Report) , BioNTech SE (BNTX - Free Report) , Delta Air Lines, Inc. (DAL - Free Report) , The Walt Disney Company (DIS - Free Report) and Peloton Interactive, Inc. (PTON - Free Report) .

What a Vaccine Means for the Stock Market

Pfizer may have discovered the COVID-19 vaccine that the world has been waiting for since this pandemic began. The equity markets are soaring this morning, being led by the cyclical underperformers, while 2020's parabolic tech stocks take a seat on the sidelines for once.

The world has been living in a state of fear about an unseen killer. This microscopic terror put the world into a medically induced recession, but our resilient economy combined with much needed monetary & fiscal support has allowed us to recover quickly.

A successful vaccine announcement was the final reprieve that the stock market needed for a full recovery. Pfizer announced a COVID-19 vaccine with BioNTech, which has been given an initial effectiveness rating of 90%.

The vaccine news initiated an excess of positive market sentiment today. Other big vaccine players are expected to come out with vaccine results of their own in the coming weeks. 

The markets are pricing in the end of the pandemic. This means more foot traffic and less click traffic.

Market Action 

The value-driven Dow index and the broader large-cap S&P 500 are hitting all-time highs today, while the tech-powered Nasdaq 100 is teetering on positive for the day, sitting 2% below the all-time highs it hit in early September.

Today, investors are finally putting their money back into beaten-down names like Delta Air Lines and Disney, which are seeing double-digit gains today. Cyclical value stocks are finally taking the reins, and those savvy investors that have been buying up these value names are finally reaping the returns.

Stay at home stocks are showing weakness today. Digitally-driven stocks propelled by the work, shop, and live from home initiative are seeing profit-pulling as investors rotate into cyclical underperformers whose uncertain future just got a whole lot brighter.

Quarantine stocks like Peloton are experiencing a pullback today as investors price in economic normality.

What's Next For The Stock Market

The announced vaccine still isn't anticipated to be universally available until 2021, but as we all know, the stock market is forward-looking. What does the 'new normal' for society look like once COVID-19 is in the rearview mirror?

I can tell you that it will not be the same world that we left behind in 2019. The pandemic has conditioned society to leverage technology more than ever before. Society has rapidly digitized in 2020, and that is something that is only going to continue as the 4th industrial revolution commences. Cloud-computing, ecommerce, the internet of things, 5G technology, and artificial intelligence (AI) will be an increasingly significant part of everyday humanity.

When I look to the future, I see a world bound by technology and flourishing from the ease and convenience that it has provided. Despite today's hold on technology stocks, my portfolio is still very much tech-focused.

Final Thoughts

I believe we are getting up to rich valuations as all the major indexes search for new all-time highs today. There is an enormous amount of optimism in the market, and this makes me hesitant to put on any large positions. As Warren Buffett said, "Be fearful when others are greedy."

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.